NEW ORLEANS, Nov. 16, 2010 (GLOBE NEWSWIRE) -- Protea Biosciences, Inc., a leading developer of technology for biomolecular analysis, announced today that the company has completed an expansion of its GLP Bioanalytical Laboratory, including the introduction of quantitative proteomics mass spectrometry services. The announcement was made today at the Annual Meeting of the American Association of Pharmaceutical Scientists (AAPS).